{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T05:08:27Z","timestamp":1782623307900,"version":"3.54.5"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hypertens Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11906-025-01337-4","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T16:40:18Z","timestamp":1753116018000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Sympathetic Nervous System in Heart Failure: Targets for Treatments"],"prefix":"10.1007","volume":"27","author":[{"given":"Muhammad Sameer","family":"Arshad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veraprapas","family":"Kittipibul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marat","family":"Fudim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,21]]},"reference":[{"issue":"1","key":"1337_CR1","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/J.CARDFAIL.2024.07.001","volume":"31","author":"B Bozkurt","year":"2025","unstructured":"Bozkurt B, Ahmad T, Alexander K, Baker WL, Bosak K, Breathett K, Carter S, Drazner MH, Dunlay SM, Fonarow GC, Greene SJ, Heidenreich P, Ho JE, Hsich E, Ibrahim NE, Jones LM, Khan SS, Khazanie P, Koelling T, Lee CS, Morris AA, Page RL, Pandey A, Piano MR, Sandhu AT, Stehlik J, Stevenson LW, Teerlink J, Vest AR, Yancy C, Ziaeian B. HF STATS 2024: heart failure epidemiology and outcomes statistics an updated 2024 report from the Heart Failure Society of America. J Card Fail. 2025;31(1):66\u2013116. https:\/\/doi.org\/10.1016\/J.CARDFAIL.2024.07.001","journal-title":"J Card Fail"},{"issue":"11","key":"1337_CR2","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1161\/CIRCRESAHA.114.302589\/ASSET\/94C8F76D-13A3-4763-9A8F-862D40484BFC\/ASSETS\/GRAPHIC\/1815FIG02.JPEG","volume":"114","author":"VG Florea","year":"2014","unstructured":"Florea VG, Cohn JN. The autonomic nervous system and heart failure. Circ Res. 2014;114(11):1815\u201326. https:\/\/doi.org\/10.1161\/CIRCRESAHA.114.302589\/ASSET\/94C8F76D-13A3-4763-9A8F-862D40484BFC\/ASSETS\/GRAPHIC\/1815FIG02.JPEG","journal-title":"Circ Res"},{"issue":"2","key":"1337_CR3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/J.JJCC.2011.12.006","volume":"59","author":"T Kishi","year":"2012","unstructured":"Kishi T. Heart failure as an autonomic nervous system dysfunction. J Cardiol. 2012;59(2):117\u201322. https:\/\/doi.org\/10.1016\/J.JJCC.2011.12.006","journal-title":"J Cardiol"},{"issue":"1","key":"1337_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12933-021-01356-W","volume":"20","author":"P Valensi","year":"2021","unstructured":"Valensi P. Autonomic nervous system activity changes in patients with hypertension and overweight: role and therapeutic implications. Cardiovasc Diabetol 2021 201. 2021;20(1):1\u201312. https:\/\/doi.org\/10.1186\/S12933-021-01356-W","journal-title":"Cardiovasc Diabetol 2021 201"},{"issue":"1","key":"1337_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/J.CCL.2013.09.010","volume":"32","author":"DY Zhang","year":"2014","unstructured":"Zhang DY, Anderson AS. The sympathetic nervous system and heart failure. Cardiol Clin. 2014;32(1):33. https:\/\/doi.org\/10.1016\/J.CCL.2013.09.010","journal-title":"Cardiol Clin"},{"key":"1337_CR6","doi-asserted-by":"publisher","first-page":"857538","DOI":"10.3389\/FPHYS.2022.857538\/BIBTEX","volume":"13","author":"MA Konstam","year":"2022","unstructured":"Konstam MA, Mann DL, Udelson JJE, Ardell JL, De Ferrari GM, Cowie MR, Klein HU, Gregory DD, Massaro JM, Libbus I, DiCarlo LA, Butler J, Parker JD, Teerlink JR. Advances in our clinical understanding of autonomic regulation therapy using vagal nerve stimulation in patients living with heart failure. Front Physiol. 2022;13:857538. https:\/\/doi.org\/10.3389\/FPHYS.2022.857538\/BIBTEX","journal-title":"Front Physiol"},{"issue":"10","key":"1337_CR7","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/J.JACC.2018.12.064","volume":"73","author":"JJ Goldberger","year":"2019","unstructured":"Goldberger JJ, Arora R, Buckley U, Shivkumar K. Autonomic nervous system dysfunction: JACC focus seminar. J Am Coll Cardiol. 2019;73(10):1189\u2013206. https:\/\/doi.org\/10.1016\/J.JACC.2018.12.064","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"1337_CR8","doi-asserted-by":"publisher","first-page":"e263","DOI":"10.1016\/J.JACC.2021.12.012","volume":"79","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW. 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022;79(17):e263\u2013421. https:\/\/doi.org\/10.1016\/J.JACC.2021.12.012","journal-title":"J Am Coll Cardiol"},{"issue":"36","key":"1337_CR9","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/EURHEARTJ\/EHAB368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, Baumbach A, B\u00f6hm M, Burri H, \u010celutkiene J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gardner RS, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Piepoli MF, Price S, Rosano GMC, Ruschitzka F, Skibelund AK, de Boer RA, Schulze PC, Abdelhamid M, Aboyans V, Adamopoulos S, Anker SD, Arbelo E, Asteggiano R, Bauersachs J, Bayes-Genis A, Borger MA, Budts W, Cikes M, Damman K, Delgado V, Dendale P, Dilaveris P, Drexel H, Ezekowitz J, Falk V, Fauchier L, Filippatos G, Fraser A, Frey N, Gale CP, Gustafsson F, Harris J, Iung B, Janssens S, Jessup M, Konradi A, Kotecha D, Lambrinou E, Lancellotti P, Landmesser U, Leclercq C, Lewis BS, Leyva F, Linhart A, L\u00f8chen ML, Lund LH, Mancini D, Masip J, Milicic D, Mueller C, Nef H, Nielsen JC, Neubeck L, Noutsias M, Petersen SE, Petronio AS, Ponikowski P, Prescott E, Rakisheva A, Richter D, Schlyakhto E, Seferovic P, Senni M, Sitges M, Sousa-Uva M, Tocchetti CG, Touyz R, Tschoepe C, Waltenberger J, Krim M, Hayrapetyan H, Moertl D, Mustafayev I, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599\u2013726. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHAB368","journal-title":"Eur Heart J"},{"issue":"3","key":"1337_CR10","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1161\/HYPERTENSIONAHA.109.140665","volume":"55","author":"K Heusser","year":"2010","unstructured":"Heusser K, Tank J, Engeli S, Diedrich A, Menne J, Eckert S, Peters T, Sweep FCGJ, Haller H, Pichlmaier AM, Luft FC, Jordan J. Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients. Hypertens (Dallas Tex 1979). 2010;55(3):619\u201326. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.109.140665","journal-title":"Hypertens (Dallas Tex 1979)"},{"issue":"6","key":"1337_CR11","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1161\/01.CIR.81.6.1959","volume":"81","author":"W Wang","year":"1990","unstructured":"Wang W, Chen JS, Zucker IH. Carotid sinus baroreceptor sensitivity in experimental heart failure. Circulation. 1990;81(6):1959\u201366. https:\/\/doi.org\/10.1161\/01.CIR.81.6.1959","journal-title":"Circulation"},{"issue":"5","key":"1337_CR12","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/J.JACC.2009.03.061","volume":"54","author":"JS Floras","year":"2009","unstructured":"Floras JS. Sympathetic nervous system activation in human heart failure: clinical implications of an updated model. J Am Coll Cardiol. 2009;54(5):375\u201385. https:\/\/doi.org\/10.1016\/J.JACC.2009.03.061","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"1337_CR13","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1042\/CS20130294","volume":"126","author":"IH Zucker","year":"2014","unstructured":"Zucker IH, Xiao L, Haack KKV. The central renin-angiotensin system and sympathetic nerve activity in chronic heart failure. Clin Sci (Lond). 2014;126(10):695\u2013706. https:\/\/doi.org\/10.1042\/CS20130294","journal-title":"Clin Sci (Lond)"},{"key":"1337_CR14","doi-asserted-by":"publisher","unstructured":"Esler M, Kaye D, Lambert G, Esler D, Jennings G. Adrenergic nervous system in heart failure. Am J Cardiol. 1997;80(11A). https:\/\/doi.org\/10.1016\/S0002-9149(97)00844-8","DOI":"10.1016\/S0002-9149(97)00844-8"},{"issue":"16","key":"1337_CR15","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1161\/01.CIR.103.16.2072","volume":"103","author":"MT La Rovere","year":"2001","unstructured":"La Rovere MT, Pinna GD, Hohnloser SH, Marcus FI, Mortara A, Nohara R, Bigger J, Camm AJ, Schwartz PJ. Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials. Circulation. 2001;103(16):2072\u20137. https:\/\/doi.org\/10.1161\/01.CIR.103.16.2072","journal-title":"Circulation"},{"issue":"2","key":"1337_CR16","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1152\/PHYSREV.00007.2009","volume":"90","author":"SC Malpas","year":"2010","unstructured":"Malpas SC. Sympathetic nervous system overactivity and its role in the development of cardiovascular disease. Physiol Rev. 2010;90(2):513\u201357. https:\/\/doi.org\/10.1152\/PHYSREV.00007.2009","journal-title":"Physiol Rev"},{"issue":"MAR","key":"1337_CR17","doi-asserted-by":"publisher","first-page":"238992","DOI":"10.3389\/FNINS.2017.00162\/BIBTEX","volume":"11","author":"E Toschi-Dias","year":"2017","unstructured":"Toschi-Dias E, Rondon MUPB, Cogliati C, Paolocci N, Tobaldini E, Montano N. Contribution of autonomic reflexes to the hyperadrenergic state in heart failure. Front Neurosci. 2017;11(MAR):238992. https:\/\/doi.org\/10.3389\/FNINS.2017.00162\/BIBTEX","journal-title":"Front Neurosci"},{"issue":"1","key":"1337_CR18","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/CPHY.C100069","volume":"2","author":"P Kumar","year":"2012","unstructured":"Kumar P, Prabhakar NR. Peripheral chemoreceptors: function and plasticity of the carotid body. Compr Physiol. 2012;2(1):141. https:\/\/doi.org\/10.1002\/CPHY.C100069","journal-title":"Compr Physiol"},{"issue":"1","key":"1337_CR19","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1161\/HYPERTENSIONAHA.106.076083\/SUPPL_FILE\/SUP_ZHY076083-S2.DOC","volume":"50","author":"HD Schultz","year":"2007","unstructured":"Schultz HD, Li YL, Ding Y. Arterial chemoreceptors and sympathetic nerve activity: implications for hypertension and heart failure. Hypertension. 2007;50(1):6\u201313. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.106.076083\/SUPPL_FILE\/SUP_ZHY076083-S2.DOC","journal-title":"Hypertension"},{"issue":"2","key":"1337_CR20","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1113\/EXPPHYSIOL.2014.079517","volume":"100","author":"HD Schultz","year":"2015","unstructured":"Schultz HD, Marcus NJ, Del Rio R. Mechanisms of carotid body chemoreflex dysfunction during heart failure. Exp Physiol. 2015;100(2):124\u20139. https:\/\/doi.org\/10.1113\/EXPPHYSIOL.2014.079517","journal-title":"Exp Physiol"},{"issue":"4","key":"1337_CR21","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/S11906-013-0368-X","volume":"15","author":"HD Schultz","year":"2013","unstructured":"Schultz HD, Marcus NJ, Del Rio R. Role of the carotid body in the pathophysiology of heart failure. Curr Hypertens Rep. 2013;15(4):356. https:\/\/doi.org\/10.1007\/S11906-013-0368-X","journal-title":"Curr Hypertens Rep"},{"issue":"6","key":"1337_CR22","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/S1388-9842(01)00189-1","volume":"3","author":"MG Hennersdorf","year":"2001","unstructured":"Hennersdorf MG, Hillebrand S, Perings C, Strauer BE. Chemoreflexsensitivity in chronic heart failure patients. Eur J Heart Fail. 2001;3(6):679\u201384. https:\/\/doi.org\/10.1016\/S1388-9842(01)00189-1","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"1337_CR23","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1097\/HJH.0B013E328350136C","volume":"30","author":"F Despas","year":"2012","unstructured":"Despas F, Lambert E, Vaccaro A, Labrunee M, Franchitto N, Lebrin M, Galinier M, Senard JM, Lambert G, Esler M, Pathak A. Peripheral chemoreflex activation contributes to sympathetic baroreflex impairment in chronic heart failure. J Hypertens. 2012;30(4):753\u201360. https:\/\/doi.org\/10.1097\/HJH.0B013E328350136C","journal-title":"J Hypertens"},{"issue":"1","key":"1337_CR24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1161\/HYPERTENSIONAHA.111.00064\/-\/DC1","volume":"61","author":"JFR Paton","year":"2013","unstructured":"Paton JFR, Sobotka PA, Fudim M, Engleman ZJ, Hart ECJ, McBryde FD, Abdala AP, Marina N, Gourine AV, Lobo M, Patel N, Burchell A, Ratcliffe L, Nightingale A. The carotid body as a therapeutic target for the treatment of sympathetically mediated diseases. Hypertension. 2013;61(1):5\u201313. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.111.00064\/-\/DC1","journal-title":"Hypertension"},{"issue":"25","key":"1337_CR25","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1016\/J.JACC.2013.07.079","volume":"62","author":"R Del Rio","year":"2013","unstructured":"Del Rio R, Marcus NJ, Schultz HD. Carotid chemoreceptor ablation improves survival in heart failure: rescuing autonomic control of cardiorespiratory function. J Am Coll Cardiol. 2013;62(25):2422\u201330. https:\/\/doi.org\/10.1016\/J.JACC.2013.07.079","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"1337_CR26","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1093\/BJACEACCP\/MKV017","volume":"16","author":"D Harper","year":"2016","unstructured":"Harper D, Chandler B. Splanchnic circulation. BJA Educ. 2016;16(2):66\u201371. https:\/\/doi.org\/10.1093\/BJACEACCP\/MKV017","journal-title":"BJA Educ"},{"issue":"3","key":"1337_CR27","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1161\/CIRCHEARTFAILURE.121.009340\/SUPPL_FILE\/CIRCHF_CIRCHF-2021-009340_SUPP1.PDF","volume":"15","author":"M Fudim","year":"2022","unstructured":"Fudim M, Khan MS, Paracha AA, Sunagawa K, Burkhoff D. Targeting preload in heart failure: splanchnic nerve blockade and beyond. Circ Hear Fail. 2022;15(3):211\u201320. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.121.009340\/SUPPL_FILE\/CIRCHF_CIRCHF-2021-009340_SUPP1.PDF","journal-title":"Circ Hear Fail"},{"issue":"48","key":"1337_CR28","doi-asserted-by":"publisher","first-page":"4255","DOI":"10.1093\/EURHEARTJ\/EHY682","volume":"39","author":"M Fudim","year":"2018","unstructured":"Fudim M, Ganesh A, Green C, Jones WS, Blazing MA, DeVore AD, Felker GM, Kiefer TL, Kong DF, Boortz-Marx RL, Hernandez AF, Patel MR. Splanchnic nerve block for decompensated chronic heart failure: splanchnic-HF. Eur Heart J. 2018;39(48):4255\u20136. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHY682","journal-title":"Eur Heart J"},{"issue":"2","key":"1337_CR29","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1161\/01.RES.46.2.181","volume":"46","author":"CV Greenway","year":"1980","unstructured":"Greenway CV, Innes IR. Effects of splanchnic nerve stimulation on cardiac preload, afterload, and output in cats. Circ Res. 1980;46(2):181\u20139. https:\/\/doi.org\/10.1161\/01.RES.46.2.181","journal-title":"Circ Res"},{"issue":"4","key":"1337_CR30","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1002\/CPHY.C150046","volume":"6","author":"JL Ardell","year":"2016","unstructured":"Ardell JL, Armour JA, Neurocardiology. Structure-based function. Compr Physiol. 2016;6(4):1635\u201353. https:\/\/doi.org\/10.1002\/CPHY.C150046","journal-title":"Compr Physiol"},{"issue":"21","key":"1337_CR31","doi-asserted-by":"publisher","first-page":"13311","DOI":"10.3390\/IJMS232113311","volume":"23","author":"Y Wang","year":"2022","unstructured":"Wang Y, Denton K, Li YL. Stellate ganglia and cardiac sympathetic overactivation in heart failure. Int J Mol Sci. 2022;23(21):13311. https:\/\/doi.org\/10.3390\/IJMS232113311","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1337_CR32","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1161\/01.HYP.0000200157.25792.26\/SUPPL_FILE\/SUP_ZHY059451-S2.DOC","volume":"47","author":"MM Kreusser","year":"2006","unstructured":"Kreusser MM, Haass M, Buss SJ, Hardt SE, Gerber SH, Kinscherf R, Katus HA, Backs J. Injection of nerve growth factor into stellate ganglia improves norepinephrine reuptake into failing hearts. Hypertension. 2006;47(2):209\u201315. https:\/\/doi.org\/10.1161\/01.HYP.0000200157.25792.26\/SUPPL_FILE\/SUP_ZHY059451-S2.DOC","journal-title":"Hypertension"},{"issue":"2","key":"1337_CR33","doi-asserted-by":"publisher","first-page":"e001359","DOI":"10.1161\/CIRCEP.115.001359","volume":"9","author":"RT Gardner","year":"2016","unstructured":"Gardner RT, Ripplinger CM, Myles RC, Habecker BA. Molecular mechanisms of sympathetic remodeling and arrhythmias. Circ Arrhythm Electrophysiol. 2016;9(2):e001359. https:\/\/doi.org\/10.1161\/CIRCEP.115.001359","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1337_CR34","doi-asserted-by":"publisher","first-page":"665298","DOI":"10.3389\/FPHYS.2021.665298\/TEXT","volume":"12","author":"TE Zandstra","year":"2021","unstructured":"Zandstra TE, Notenboom RGE, Wink J, Ki\u00e8s P, Vliegen HW, Egorova AD, Schalij MJ, De Ruiter MC, Jongbloed MRM. Asymmetry and heterogeneity: part and parcel in cardiac autonomic innervation and function. Front Physiol. 2021;12:665298. https:\/\/doi.org\/10.3389\/FPHYS.2021.665298\/TEXT","journal-title":"Front Physiol"},{"issue":"2","key":"1337_CR35","doi-asserted-by":"publisher","first-page":"a034173","DOI":"10.1101\/CSHPERSPECT.A034173","volume":"10","author":"MJ Capilupi","year":"2020","unstructured":"Capilupi MJ, Kerath SM, Becker LB, Zucker B, Pavlov VA, Tracey KJ. Vagus nerve stimulation and the cardiovascular system. Cold Spring Harb Perspect Med. 2020;10(2):a034173. https:\/\/doi.org\/10.1101\/CSHPERSPECT.A034173","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"6868","key":"1337_CR36","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/415198a","volume":"415","author":"DM Bers","year":"2002","unstructured":"Bers DM. Cardiac excitation\u2013contraction coupling. Nat 2002 4156868. 2002;415(6868):198\u2013205. https:\/\/doi.org\/10.1038\/415198a","journal-title":"Nat 2002 4156868"},{"issue":"4","key":"1337_CR37","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1093\/CVR\/CVV017","volume":"105","author":"T Eschenhagen","year":"2015","unstructured":"Eschenhagen T, Mummery C, Knollmann BC. Modelling sarcomeric cardiomyopathies in the dish: from human heart samples to iPSC cardiomyocytes. Cardiovasc Res. 2015;105(4):424\u201338. https:\/\/doi.org\/10.1093\/CVR\/CVV017","journal-title":"Cardiovasc Res"},{"issue":"4","key":"1337_CR38","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/J.BBRC.2004.07.121","volume":"322","author":"BJ Wilkins","year":"2004","unstructured":"Wilkins BJ, Molkentin JD. Calcium\u2013calcineurin signaling in the regulation of cardiac hypertrophy. Biochem Biophys Res Commun. 2004;322(4):1178\u201391. https:\/\/doi.org\/10.1016\/J.BBRC.2004.07.121","journal-title":"Biochem Biophys Res Commun"},{"issue":"25","key":"1337_CR39","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1161\/CIRCULATIONAHA.110.942268\/ASSET\/988FE6F6-C326-4084-8661-3BEA8AED00AC\/ASSETS\/GRAPHIC\/ZHC0501090450003.JPEG","volume":"122","author":"I Kehat","year":"2010","unstructured":"Kehat I, Molkentin JD. Molecular pathways underlying cardiac remodeling during pathophysiological stimulation. Circulation. 2010;122(25):2727\u201335. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.942268\/ASSET\/988FE6F6-C326-4084-8661-3BEA8AED00AC\/ASSETS\/GRAPHIC\/ZHC0501090450003.JPEG","journal-title":"Circulation"},{"issue":"4","key":"1337_CR40","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/S00018-013-1349-6","volume":"71","author":"P Kong","year":"2014","unstructured":"Kong P, Christia P, Frangogiannis NG. The pathogenesis of cardiac fibrosis. Cell Mol Life Sci. 2014;71(4):549\u201374. https:\/\/doi.org\/10.1007\/S00018-013-1349-6","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"1337_CR41","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S0735-1097(99)00630-0","volume":"35","author":"JN Cohn","year":"2000","unstructured":"Cohn JN, Ferrari R, Sharpe N. Cardiac remodeling\u2014concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. J Am Coll Cardiol. 2000;35(3):569\u201382. https:\/\/doi.org\/10.1016\/S0735-1097(99)00630-0","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"1337_CR42","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1161\/CIRCRESAHA.113.302549\/ASSET\/79BA0D81-DE94-489F-9CDB-7FAF1E743AF3\/ASSETS\/GRAPHIC\/1004FIG08.JPEG","volume":"114","author":"MJ Shen","year":"2014","unstructured":"Shen MJ, Zipes DP. Role of the autonomic nervous system in modulating cardiac arrhythmias. Circ Res. 2014;114(6):1004\u201321. https:\/\/doi.org\/10.1161\/CIRCRESAHA.113.302549\/ASSET\/79BA0D81-DE94-489F-9CDB-7FAF1E743AF3\/ASSETS\/GRAPHIC\/1004FIG08.JPEG","journal-title":"Circ Res"},{"issue":"Pt 23","key":"1337_CR43","doi-asserted-by":"publisher","first-page":"6093","DOI":"10.1113\/JPHYSIOL.2012.236117","volume":"590","author":"TL Domeier","year":"2012","unstructured":"Domeier TL, Maxwell JT, Blatter LA. \u03b2-Adrenergic stimulation increases the intra-sarcoplasmic reticulum Ca2\u2009+\u2009threshold for Ca2\u2009+\u2009wave generation. J Physiol. 2012;590(Pt 23):6093. https:\/\/doi.org\/10.1113\/JPHYSIOL.2012.236117","journal-title":"J Physiol"},{"key":"1337_CR44","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/J.YJMCC.2022.08.361","volume":"172","author":"R Doste","year":"2022","unstructured":"Doste R, Coppini R, Bueno-Orovio A. Remodelling of potassium currents underlies arrhythmic action potential prolongation under beta-adrenergic stimulation in hypertrophic cardiomyopathy. J Mol Cell Cardiol. 2022;172:120\u201331. https:\/\/doi.org\/10.1016\/J.YJMCC.2022.08.361","journal-title":"J Mol Cell Cardiol"},{"issue":"8","key":"1337_CR45","doi-asserted-by":"publisher","first-page":"373","DOI":"10.4330\/WJC.V12.I8.373","volume":"12","author":"JA Borovac","year":"2020","unstructured":"Borovac JA, D\u2019Amario D, Bozic J, Glavas D. Sympathetic nervous system activation and heart failure: current state of evidence and the pathophysiology in the light of novel biomarkers. World J Cardiol. 2020;12(8):373. https:\/\/doi.org\/10.4330\/WJC.V12.I8.373","journal-title":"World J Cardiol"},{"issue":"19","key":"1337_CR46","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1016\/J.JACC.2009.05.015","volume":"54","author":"F Triposkiadis","year":"2009","unstructured":"Triposkiadis F, Karayannis G, Giamouzis G, Skoularigis J, Louridas G, Butler J. The sympathetic nervous system in heart failure: physiology, pathophysiology, and clinical implications. J Am Coll Cardiol. 2009;54(19):1747\u201362. https:\/\/doi.org\/10.1016\/J.JACC.2009.05.015","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"1337_CR47","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3390\/JCDD12040124","volume":"12","author":"D Mocan","year":"2025","unstructured":"Mocan D, Jipa R, Jipa DA, Lala RI, Rasinar FC, Groza I, Sabau R, Bratu DS, Balta DF, Cioban ST, Puschita M. Unveiling the systemic impact of congestion in heart failure: a narrative review of multisystem pathophysiology and clinical implications. J Cardiovasc Dev Dis 2025. 2025;12(4):124. https:\/\/doi.org\/10.3390\/JCDD12040124","journal-title":"J Cardiovasc Dev Dis 2025"},{"key":"1337_CR48","doi-asserted-by":"publisher","first-page":"3239057","DOI":"10.1155\/2022\/3239057","volume":"2022","author":"K Ma","year":"2022","unstructured":"Ma K, Gao W, Xu H, Liang W, Ma G. Role and mechanism of the renin-angiotensin-aldosterone system in the onset and development of cardiorenal syndrome. J Renin-Angiotensin-Aldosterone Syst JRAAS. 2022;2022:3239057. https:\/\/doi.org\/10.1155\/2022\/3239057","journal-title":"J Renin-Angiotensin-Aldosterone Syst JRAAS"},{"issue":"2","key":"1337_CR49","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1152\/PHYSIOL.00035.2014","volume":"30","author":"TE Lohmeier","year":"2015","unstructured":"Lohmeier TE, Iliescu R. The baroreflex as a long-term controller of arterial pressure. Physiol (Bethesda). 2015;30(2):148\u201358. https:\/\/doi.org\/10.1152\/PHYSIOL.00035.2014","journal-title":"Physiol (Bethesda)"},{"issue":"11","key":"1337_CR50","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1002\/EJHF.921","volume":"19","author":"M van Bilsen","year":"2017","unstructured":"van Bilsen M, Patel HC, Bauersachs J, B\u00f6hm M, Borggrefe M, Brutsaert D, Coats AJS, de Boer RA, de Keulenaer GW, Filippatos GS, Floras J, Grassi G, Jankowska EA, Kornet L, Lunde IG, Maack C, Mahfoud F, Pollesello P, Ponikowski P, Ruschitzka F, Sabbah HN, Schultz HD, Seferovic P, Slart RHJA, Taggart P, Tocchetti CG, Van Laake LW, Zannad F, Heymans S, Lyon AR. The autonomic nervous system as a therapeutic target in heart failure: a scientific position statement from the translational research committee of the heart failure association of the European Society of Cardiology. Eur J Heart Fail. 2017;19(11):1361\u201378. https:\/\/doi.org\/10.1002\/EJHF.921","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"1337_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.JACC.2020.05.015","volume":"76","author":"MR Zile","year":"2020","unstructured":"Zile MR, Lindenfeld JA, Weaver FA, Zannad F, Galle E, Rogers T, Abraham WT. Baroreflex activation therapy in patients with heart failure with reduced ejection fraction. J Am Coll Cardiol. 2020;76(1):1\u201313. https:\/\/doi.org\/10.1016\/J.JACC.2020.05.015","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"1337_CR52","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1002\/EJHF.2573","volume":"24","author":"AJS Coats","year":"2022","unstructured":"Coats AJS, Abraham WT, Zile MR, Lindenfeld JA, Weaver FA, Fudim M, Bauersachs J, Duval S, Galle E, Zannad F. Baroreflex activation therapy with the barostim\u2122 device in patients with heart failure with reduced ejection fraction: a patient level meta-analysis of randomized controlled trials. Eur J Heart Fail. 2022;24(9):1665. https:\/\/doi.org\/10.1002\/EJHF.2573","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"1337_CR53","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/J.JCHF.2015.02.006","volume":"3","author":"WT Abraham","year":"2015","unstructured":"Abraham WT, Zile MR, Weaver FA, Butter C, Ducharme A, Halbach M, Klug D, Lovett EG, M\u00fcller-Ehmsen J, Schafer JE, Senni M, Swarup V, Wachter R, Little WC. Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction. JACC Heart Fail. 2015;3(6):487\u201396. https:\/\/doi.org\/10.1016\/J.JCHF.2015.02.006","journal-title":"JACC Heart Fail"},{"issue":"1","key":"1337_CR54","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1161\/01.CIR.0000105721.71640.DA","volume":"109","author":"M Li","year":"2004","unstructured":"Li M, Zheng C, Sato T, Kawada T, Sugimachi M, Sunagawa K. Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats. Circulation. 2004;109(1):120\u20134. https:\/\/doi.org\/10.1161\/01.CIR.0000105721.71640.DA","journal-title":"Circulation"},{"issue":"7","key":"1337_CR55","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1093\/EURHEARTJ\/EHQ391","volume":"32","author":"GM De Ferrari","year":"2011","unstructured":"De Ferrari GM, Crijns HJGM, Borggrefe M, Milasinovic G, Smid J, Zabel M, Gavazzi A, Sanzo A, Dennert R, Kuschyk J, Raspopovic S, Klein H, Swedberg K, Schwartz PJ. Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure. Eur Heart J. 2011;32(7):847\u201355. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHQ391","journal-title":"Eur Heart J"},{"issue":"11","key":"1337_CR56","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/J.CARDFAIL.2014.08.009","volume":"20","author":"RK Premchand","year":"2014","unstructured":"Premchand RK, Sharma K, Mittal S, Monteiro R, Dixit S, Libbus I, Dicarlo LA, Ardell JL, Rector TS, Amurthur B, Kenknight BH, Anand IS. Autonomic regulation therapy via left or right cervical vagus nerve stimulation in patients with chronic heart failure: results of the ANTHEM-HF trial. J Card Fail. 2014;20(11):808\u201316. https:\/\/doi.org\/10.1016\/J.CARDFAIL.2014.08.009","journal-title":"J Card Fail"},{"issue":"7","key":"1337_CR57","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1093\/EURHEARTJ\/EHU345","volume":"36","author":"F Zannad","year":"2015","unstructured":"Zannad F, De Ferrari GM, Tuinenburg AE, Wright D, Brugada J, Butter C, Klein H, Stolen C, Meyer S, Stein KM, Ramuzat A, Schubert B, Daum D, Neuzil P, Botman C, Castel MA, D\u2019Onofrio A, Solomon SD, Wold N, Ruble SB. Chronic vagal stimulation for the treatment of low ejection fraction heart failure: results of the neural cardiac therapy for heart failure (NECTAR-HF) randomized controlled trial. Eur Heart J. 2015;36(7):425\u201333. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHU345","journal-title":"Eur Heart J"},{"issue":"2","key":"1337_CR58","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/J.JACC.2016.03.525","volume":"68","author":"MR Gold","year":"2016","unstructured":"Gold MR, Van Veldhuisen DJ, Hauptman PJ, Borggrefe M, Kubo SH, Lieberman RA, Milasinovic G, Berman BJ, Djordjevic S, Neelagaru S, Schwartz PJ, Starling RC, Mann DL. Vagus nerve stimulation for the treatment of heart failure: the INOVATE-HF trial. J Am Coll Cardiol. 2016;68(2):149\u201358. https:\/\/doi.org\/10.1016\/J.JACC.2016.03.525","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"1337_CR59","doi-asserted-by":"publisher","first-page":"e024481","DOI":"10.1161\/JAHA.121.024481","volume":"11","author":"V Kittipibul","year":"2022","unstructured":"Kittipibul V, Fudim M. Tackling inflammation in heart failure with preserved ejection fraction: resurrection of vagus nerve stimulation?? J Am Hear Assoc Cardiovasc Cerebrovasc Dis. 2022;11(3):e024481. https:\/\/doi.org\/10.1161\/JAHA.121.024481","journal-title":"J Am Hear Assoc Cardiovasc Cerebrovasc Dis"},{"issue":"9","key":"1337_CR60","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/J.JCHF.2020.04.010","volume":"8","author":"M Fudim","year":"2020","unstructured":"Fudim M, Boortz-Marx RL, Ganesh A, DeVore AD, Patel CB, Rogers JG, Coburn A, Johnson I, Paul A, Coyne BJ, Rao SV, Gutierrez JA, Kiefer TL, Kong DF, Green CL, Jones WS, Felker GM, Hernandez AF, Patel MR. Splanchnic nerve block for chronic heart failure. JACC Heart Fail. 2020;8(9):742\u201352. https:\/\/doi.org\/10.1016\/J.JCHF.2020.04.010","journal-title":"JACC Heart Fail"},{"key":"1337_CR61","doi-asserted-by":"publisher","unstructured":"Gajewski P, Fudim M, Kittipibul V, Engelman ZJ, Biegus J, Zymli\u0144ski R, Ponikowski P. Early hemodynamic changes following surgical ablation of the right greater splanchnic nerve for the treatment of heart failure with preserved ejection fraction. J Clin Med. 2022;11(4). https:\/\/doi.org\/10.3390\/JCM11041063","DOI":"10.3390\/JCM11041063"},{"issue":"12","key":"1337_CR62","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1001\/JAMACARDIO.2024.2612","volume":"9","author":"M Fudim","year":"2024","unstructured":"Fudim M, Borlaug BA, Mohan RC, Price MJ, Fail P, Goyal P, Hummel SL, Zirakashvili T, Shaburishvili T, Patel RB, Reddy VY, Nielsen CD, Chetcuti SJ, Sukul D, Gulati R, Kim L, Benzuly K, Mitter SS, Klein L, Uriel N, Augostini RS, Blair JE, Rocha-Singh K, Burkhoff D, Patel MR, Somo SI, Litwin SE, Shah SJ. Endovascular ablation of the greater splanchnic nerve in heart failure with preserved ejection fraction: the REBALANCE-HF randomized clinical trial. JAMA Cardiol. 2024;9(12):1143\u201353. https:\/\/doi.org\/10.1001\/JAMACARDIO.2024.2612","journal-title":"JAMA Cardiol"},{"key":"1337_CR63","unstructured":"Study Details| Splanchnic X: splanchnic nerve block in heart failure with reduced ejection fraction| ClinicalTrials.gov. Accessed April 19. 2025. https:\/\/clinicaltrials.gov\/study\/NCT06733012"},{"key":"1337_CR64","doi-asserted-by":"publisher","unstructured":"Jiang H, Kittipibul V, Mahfoud F, B\u00f6hm M, Sobotka PA, Esler M, Wang J, Fudim M. The road to renal denervation for hypertension and beyond (HF): two decades of failed, succeeded, and to be determined. Heart Fail Rev. 2025;30(2). https:\/\/doi.org\/10.1007\/S10741-024-10463-1","DOI":"10.1007\/S10741-024-10463-1"},{"issue":"Suppl 1","key":"1337_CR65","doi-asserted-by":"publisher","first-page":"101","DOI":"10.4137\/CMC.S18754","volume":"9","author":"P Dhakal","year":"2015","unstructured":"Dhakal P, Liu K, Kozman H, Carhart RL, Villarreal D. Renal denervation in heart failure: a new therapeutic paradigm. Clin Med Insights Cardiol. 2015;9(Suppl 1):101. https:\/\/doi.org\/10.4137\/CMC.S18754","journal-title":"Clin Med Insights Cardiol"},{"key":"1337_CR66","doi-asserted-by":"publisher","first-page":"485109","DOI":"10.3389\/FPHYS.2019.01625\/BIBTEX","volume":"10","author":"WJ Chen","year":"2020","unstructured":"Chen WJ, Liu H, Wang ZH, Liu C, Fan JQ, Wang ZL, Xu YP, Zhang B, Gyawali L, Li Q, Ling ZY, Yin YH. The impact of renal denervation on the progression of heart failure in a canine model induced by right ventricular rapid pacing. Front Physiol. 2020;10:485109. https:\/\/doi.org\/10.3389\/FPHYS.2019.01625\/BIBTEX","journal-title":"Front Physiol"},{"issue":"33","key":"1337_CR67","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1093\/EURHEARTJ\/EHU093","volume":"35","author":"F Mahfoud","year":"2014","unstructured":"Mahfoud F, Urban D, Teller D, Linz D, Stawowy P, Hassel JH, Fries P, Dreysse S, Wellnhofer E, Schneider G, Buecker A, Schneeweis C, Doltra A, Schlaich MP, Esler MD, Fleck E, B\u00f6hm M, Kelle S. Effect of renal denervation on left ventricular mass and function in patients with resistant hypertension: data from a multi-centre cardiovascular magnetic resonance imaging trial. Eur Heart J. 2014;35(33):2224\u201331. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHU093","journal-title":"Eur Heart J"},{"issue":"3","key":"1337_CR68","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ijcard.2012.09.019","volume":"162","author":"JE Davies","year":"2013","unstructured":"Davies JE, Manisty CH, Petraco R, Barron AJ, Unsworth B, Mayet J, Hamady M, Hughes AD, Sever PS, Sobotka PA, Francis DP. First-in-man safety evaluation of renal denervation for chronic systolic heart failure: primary outcome from REACH-pilot study. Int J Cardiol. 2013;162(3):189\u201392. https:\/\/doi.org\/10.1016\/j.ijcard.2012.09.019","journal-title":"Int J Cardiol"},{"issue":"9","key":"1337_CR69","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.cardfail.2017.06.004","volume":"23","author":"I Hopper","year":"2017","unstructured":"Hopper I, Gronda E, Hoppe UC, Rundqvist B, Marwick TH, Shetty S, Hayward C, Lambert T, Hering D, Esler M, Schlaich M, Walton A, Airoldi F, Brandt MC, Cohen SA, Reiters P, Krum H. Sympathetic response and outcomes following renal denervation in patients with chronic heart failure: 12-month outcomes from the symplicity HF feasibility study. J Card Fail. 2017;23(9):702\u20137. https:\/\/doi.org\/10.1016\/j.cardfail.2017.06.004","journal-title":"J Card Fail"},{"issue":"5","key":"1337_CR70","doi-asserted-by":"publisher","first-page":"503","DOI":"10.5603\/CJ.A2018.0028","volume":"26","author":"JQ Gao","year":"2019","unstructured":"Gao JQ, Yang W, Liu ZJ. Percutaneous renal artery denervation in patients with chronic systolic heart failure: a randomized controlled trial. Cardiol J. 2019;26(5):503\u201310. https:\/\/doi.org\/10.5603\/CJ.A2018.0028","journal-title":"Cardiol J"},{"issue":"4","key":"1337_CR71","doi-asserted-by":"publisher","first-page":"E153","DOI":"10.1002\/CCD.26475","volume":"89","author":"W Chen","year":"2017","unstructured":"Chen W, Ling Z, Xu Y, Liu Z, Su L, Du H, Xiao P, Lan X, Shan Q, Yin Y. Preliminary effects of renal denervation with saline irrigated catheter on cardiac systolic function in patients with heart failure: a prospective, randomized, controlled, pilot study. Catheter Cardiovasc Interv. 2017;89(4):E153\u201361. https:\/\/doi.org\/10.1002\/CCD.26475","journal-title":"Catheter Cardiovasc Interv"},{"key":"1337_CR72","unstructured":"Study Details| A prospective. multicenter, randomized, blinded, sham-controlled, feasibility study of renal denervation in patients with chronic heart failure| ClinicalTrials.gov. Accessed April 7, 2025. https:\/\/clinicaltrials.gov\/study\/NCT04947670"},{"issue":"4","key":"1337_CR73","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1161\/HYPERTENSIONAHA.113.02419\/-\/DC1","volume":"63","author":"R Eschalier","year":"2014","unstructured":"Eschalier R, Rossignol P, Kearney-Schwartz A, Adamopoulos C, Karatzidou K, Fay R, Mandry D, Marie PY, Zannad F. Features of cardiac remodeling, associated with blood pressure and fibrosis biomarkers, are frequent in subjects with abdominal obesity. Hypertension. 2014;63(4):740\u20136. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.113.02419\/-\/DC1","journal-title":"Hypertension"},{"issue":"6","key":"1337_CR74","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/EJHF.502","volume":"18","author":"HC Patel","year":"2016","unstructured":"Patel HC, Rosen SD, Hayward C, Vassiliou V, Smith GC, Wage RR, Bailey J, Rajani R, Lindsay AC, Pennell DJ, Underwood SR, Prasad SK, Mohiaddin R, Gibbs JSR, Lyon AR, Di Mario C. Renal denervation in heart failure with preserved ejection fraction (RDT-PEF): a randomized controlled trial. Eur J Heart Fail. 2016;18(6):703\u201312. https:\/\/doi.org\/10.1002\/EJHF.502","journal-title":"Eur J Heart Fail"},{"key":"1337_CR75","unstructured":"Study Details| Renal denervation to treat heart failure with preserved ejection fraction| ClinicalTrials.gov. Accessed April 7. 2025. https:\/\/clinicaltrials.gov\/study\/NCT05030987"},{"issue":"12","key":"1337_CR76","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1093\/EURJHF\/HFT119","volume":"15","author":"WL Verloop","year":"2013","unstructured":"Verloop WL, Beeftink MMA, Nap A, Bots ML, Velthuis BK, Appelman YE, Cramer MJ, Agema WRP, Scholtens AM, Doevendans PA, Allaart CP, Voskuil M. Renal denervation in heart failure with normal left ventricular ejection fraction. Rationale and design of the DIASTOLE (DenervatIon of the renal sympathetic nerves in heart failure with nOrmal Lv ejection fraction) trial. Eur J Heart Fail. 2013;15(12):1429\u201337. https:\/\/doi.org\/10.1093\/EURJHF\/HFT119","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"1337_CR77","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"G Mancia","year":"2023","unstructured":"Mancia G, Kreutz R, Brunstr\u00f6m M, Burnier M, Grassi G, Januszewicz A, Muiesan ML, Tsioufis K, Agabiti-Rosei E, Algharably EAE, Azizi M, Benetos A, Borghi C, Hitij JB, Cifkova R, Coca A, Cornelissen V, Cruickshank JK, Cunha PG, Danser AHJ, Pinho RM, De, Delles C, Dominiczak AF, Dorobantu M, Doumas M, Fern\u00e1ndez-Alfonso MS, Halimi JM, J\u00e1rai Z, Jelakovi\u0107 B, Jordan J, Kuznetsova T, Laurent S, Lovic D, Lurbe E, Mahfoud F, Manolis A, Miglinas M, Narkiewicz K, Niiranen T, Palatini P, Parati G, Pathak A, Persu A, Polonia J, Redon J, Sarafidis P, Schmieder R, Spronck B, Stabouli S, Stergiou G, Taddei S, Thomopoulos C, Tomaszewski M, Van De Borne P, Wanner C, Weber T, Williams B, Zhang ZY, Kjeldsen SE. 2023 ESH guidelines for the management of arterial hypertension the task force for the management of arterial hypertension of the European Society of Hypertension: endorsed by The International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023;41(12):1874\u20132071. https:\/\/doi.org\/10.1097\/HJH.0000000000003480","journal-title":"J Hypertens"},{"issue":"34","key":"1337_CR78","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/EURHEARTJ\/EHAB484","volume":"42","author":"F Visseren","year":"2021","unstructured":"Visseren F, Mach F, Smulders YM, Carballo D, Koskinas KC, B\u00e4ck M, Benetos A, Biffi A, Boavida JM, Capodanno D, Cosyns B, Crawford CA, Davos CH, Desormais I, Di Angelantonio E, Duran OHF, Halvorsen S, Richard Hobbs FD, Hollander M, Jankowska EA, Michal M, Sacco S, Sattar N, Tokgozoglu L, Tonstad S, Tsioufis KP, van Dis I, van Gelder IC, Wanner C, Williams B, De Backer G, Regitz-Zagrosek V, Aamodt AH, Abdelhamid M, Aboyans V, Albus C, Asteggiano R, B\u00e4ck M, Borger MA, Brotons C, Celutkiene J, Cikes M, Cosentino F, Dagres N, De Backer T, De Bacquer D, Delgado V, Ruijter H, Den, Dendale P, Drexel H, Falk V, Fauchier L, Ference BA, Ferri\u00e8res J, Ferrini M, Fisher M, Fliser D, Giampaoli S, Gielen S, Graham I, Jennings C, Jorgensen T, Kautzky-Willer A, Kavousi M, Koenig W, Konradi A, Kotecha D, Lettino M, Lewis BS, Linhart A, L\u00f8chen ML, Makrilakis K, Mancia G, Marques-Vidal P, McEvoy JW, McGreavy P, Merkely B, Neubeck L, Nielsen JC, Perk J, Petersen SE, Petronio AS, Piepoli M, Pogosova NG, Prescott EIB, Ray KK, Reiner Z, Richter DJ, Ryd\u00e9n L, Shlyakhto E, Sitges M, Sousa-Uva M, Sudano I, Tiberi M, Touyz RM, Ungar A, Monique Verschuren WM, Wiklund O, et al. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227\u2013337. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHAB484","journal-title":"Eur Heart J"},{"issue":"3","key":"1337_CR79","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3343\/ALM.2023.43.3.225","volume":"43","author":"AE Berezin","year":"2022","unstructured":"Berezin AE, Berezin AA. Biomarkers in heart failure: from research to clinical practice. Ann Lab Med. 2022;43(3):225. https:\/\/doi.org\/10.3343\/ALM.2023.43.3.225","journal-title":"Ann Lab Med"},{"issue":"2\u20133","key":"1337_CR80","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/J.PBIOMOLBIO.2003.11.011","volume":"84","author":"S Kasparov","year":"2004","unstructured":"Kasparov S, Teschemacher AG, Hwang DY, Kim KS, Lonergan T, Paton JFR. Viral vectors as tools for studies of central cardiovascular control. Prog Biophys Mol Biol. 2004;84(2\u20133):251\u201377. https:\/\/doi.org\/10.1016\/J.PBIOMOLBIO.2003.11.011","journal-title":"Prog Biophys Mol Biol"},{"issue":"1","key":"1337_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-024-01780-w","volume":"9","author":"JH Wang","year":"2024","unstructured":"Wang JH, Gessler DJ, Zhan W, Gallagher TL, Gao G. Adeno-associated virus as a delivery vector for gene therapy of human diseases. Signal Transduct Target Ther 2024 91. 2024;9(1):1\u201333. https:\/\/doi.org\/10.1038\/s41392-024-01780-w","journal-title":"Signal Transduct Target Ther 2024 91"},{"issue":"10","key":"1337_CR82","doi-asserted-by":"publisher","first-page":"H1521","DOI":"10.1152\/AJPHEART.00491.2014","volume":"307","author":"L Yan","year":"2014","unstructured":"Yan L, Vatner SF, Vatner DE. Disruption of type 5 adenylyl cyclase prevents \u03b2-adrenergic receptor cardiomyopathy: a novel approach to \u03b2-adrenergic receptor blockade. Am J Physiol Heart Circ Physiol. 2014;307(10):H1521\u20138. https:\/\/doi.org\/10.1152\/AJPHEART.00491.2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"1337_CR83","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1001\/JAMACARDIO.2016.0008","volume":"1","author":"HK Hammond","year":"2016","unstructured":"Hammond HK, Penny WF, Traverse JH, Henry TD, Watkins MW, Yancy CW, Sweis RN, Adler ED, Patel AN, Murray DR, Ross RS, Bhargava V, Maisel A, Barnard DD, Lai NC, Dalton ND, Lee ML, Narayan SM, Blanchard DG, Gao MH. Intracoronary gene transfer of adenylyl cyclase 6 in patients with heart failure: a randomized clinical trial. JAMA Cardiol. 2016;1(2):163\u201371. https:\/\/doi.org\/10.1001\/JAMACARDIO.2016.0008","journal-title":"JAMA Cardiol"},{"issue":"1","key":"1337_CR84","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/S0735-1097(98)00524-5","volume":"33","author":"ER Azevedo","year":"1999","unstructured":"Azevedo ER, Newton GE, Parker JD. Cardiac and systemic sympathetic activity in response to clonidine in human heart failure. J Am Coll Cardiol. 1999;33(1):186\u201391. https:\/\/doi.org\/10.1016\/S0735-1097(98)00524-5","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"1337_CR85","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/s1388-9842(03)00163-6","volume":"5","author":"JN Cohn","year":"2003","unstructured":"Cohn JN, Pfeffer MA, Rouleau J, et al. Adverse mortality effect of central sympathetic inhibition with sustained-release moxonidine in patients with heart failure (MOXCON). Eur J Heart Fail. 2003;5(5):659\u201367. https:\/\/doi.org\/10.1016\/s1388-9842(03)00163-6","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"1337_CR86","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1080\/17434440.2020.1779054","volume":"17","author":"MC Bates","year":"2020","unstructured":"Bates MC, Stone GW, Chen CY, Spiering W. Device profile of the MobiusHD EVBA system for the treatment of resistant hypertension: overview of its mechanism of action, safety and efficacy. Expert Rev Med Devices. 2020;17(7):649. https:\/\/doi.org\/10.1080\/17434440.2020.1779054","journal-title":"Expert Rev Med Devices"},{"issue":"5","key":"1337_CR87","doi-asserted-by":"publisher","first-page":"100086","DOI":"10.1016\/J.SHJ.2022.100086","volume":"6","author":"K Piayda","year":"2022","unstructured":"Piayda K, Sievert K, Sievert H, Shaburishvili T, Gogorishvili I, Rothman M, Januzzi JL, Lindenfeld JA, Stone GW. Endovascular baroreflex amplification with the MobiusHD device in patients with heart failure and reduced ejection fraction: interim analysis of the first-in-human results. Struct Hear. 2022;6(5):100086. https:\/\/doi.org\/10.1016\/J.SHJ.2022.100086","journal-title":"Struct Hear"},{"issue":"6","key":"1337_CR88","doi-asserted-by":"publisher","first-page":"101121","DOI":"10.1016\/j.jscai.2023.101121","volume":"2","author":"RV Swaminathan","year":"2023","unstructured":"Swaminathan RV, East CA, Feldman DN, Fisher ND, Garasic JM, Giri JS, Kandzari DE, Kirtane AJ, Klein A, Kobayashi T, Koenig G, Li J, Secemsky E, Townsend RR, Aronow HD. SCAI position statement on renal denervation for hypertension: patient selection, operator competence, training and techniques, and organizational recommendations. J Soc Cardiovasc Angiogr Interv. 2023;2(6):101121. https:\/\/doi.org\/10.1016\/j.jscai.2023.101121","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"issue":"5","key":"1337_CR89","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/J.CARDFAIL.2022.02.010","volume":"28","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW, Beckman JA, O\u2019Gara PT, Al-Khatib SM, Armbruster AL, Birtcher KK, Cigarroa JE, de las Fuentes L, Dixon DL, Fleisher LA, Gentile F, Goldberger ZD, Gorenek B, Haynes N, Hlatky MA, Joglar JA, Jones WS, Marine JE, Mark DB, Mukherjee D, Palaniappan LP, Piano MR, Rab T, Spatz ES, Tamis-Holland JE, Wijeysundera DN, Woo YJ. 2022 AHA\/ACC\/HFSA guideline for the management of heart failure. J Card Fail. 2022;28(5):e1\u2013167. https:\/\/doi.org\/10.1016\/J.CARDFAIL.2022.02.010","journal-title":"J Card Fail"},{"key":"1337_CR90","unstructured":"Du Preez J, Matolweni LO, Greenberg J, Mntla P, Adeyemo AA, Mayosi BM. The \u03b12CDel322-325 adrenergic receptor polymorphism is not associated with heart failure due to idiopathic dilated cardiomyopathy in black Africans. Cardiovasc J Afr. 2008;19(1):15. Accessed April 7, 2025. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3975310\/"},{"issue":"8","key":"1337_CR91","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/NRCARDIO.2015.64","volume":"12","author":"NL Pereira","year":"2015","unstructured":"Pereira NL, Sargent DJ, Farkouh ME, Rihal CS. Genotype-based clinical trials in cardiovascular disease. Nat Rev Cardiol. 2015;12(8):475. https:\/\/doi.org\/10.1038\/NRCARDIO.2015.64","journal-title":"Nat Rev Cardiol"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-025-01337-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11906-025-01337-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-025-01337-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T15:03:20Z","timestamp":1770476600000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11906-025-01337-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,21]]},"references-count":91,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1337"],"URL":"https:\/\/doi.org\/10.1007\/s11906-025-01337-4","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,21]]},"assertion":[{"value":"11 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr Fudim was supported by the NIH, Bodyport, Sardocor, and Doris Duke. He is a consultant\/has ownership interesting in Abbott, Ajax, Alio Health, Alleviant, Analog, Andera, Artha, Audicor, AxonTherapies, Bayer, Bodyguide, Bodyport, Boston Scientific, Broadview, Cadence, Cardioflow, Coridea, CVRx, Daxor, Edwards LifeSciences, Echosens, EKO, Feldschuh Foundation, Fire1, FutureCardia, Galvani, Gradient, Hatteras, HemodynamiQ, Impulse Dynamics, Intershunt, Medtronic, Merck, NIMedical, NovoNordisk, NucleusRx, NXT Biomedical, Orchestra, Pharmacosmos, Presidio, Procyreon, Proton Intelligence, ReCor, Rockley, SCPharma, Shifamed, Splendo, STAT Health, Summacor, SyMap, Verily, Vironix, Viscardia, Zoll. Dr. Arshad and Dr. Kittipibul report no relevant disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"20"}}